Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
www.aging-us.com 18008 AGING
INTRODUCTION
Kidney is the main metabolic and excretory organ of
drugs, and is also the main target of drug toxicity. It has
been reported that 34.2% of acute renal failure and 20 %
of end-stage kidney disease are caused by side effects of
drugs, respectively [1]. Cisplatin (Cp) is an inorganic
platinum-based chemotherapy drug. At present, Cp is
widely used in the treatment of various malignant
tumors, including malignant tumors of the head and
neck, lung cancer, ovarian cancer, testicular cancer,
bladder cancer [2], and its efficacy is proportional to the
dose [3]. However, limiting its full clinical potential is
that it has various significant side effects, such as
myelosuppression, peripheral neuropathy, ototoxicity,
allergic reactions, nephrotoxicity, etc., of which
nephrotoxicity is its most serious side effect [4].
Clinically, a single dose of cisplatin (50~100 mg/m2)
causes the incidence of nephrotoxicity to be as high as
1/3 [5]. Therefore, the prevention and treatment of
nephrotoxicity during chemotherapy is one of the urgent
problems to be solved in clinical practice.
Mesenchymal stem cells (MSCs) are pluripotent stem
cells derived from mesoderm and have the ability to
multi-directionally differentiate into fat, osteogenesis,
cartilage and neuron, which are present in various
tissues and organs of the body [6]. MSCs can homing to
the injury site in vivo and promote tissue damage repair
by differentiation into damaged cells and paracrine
www.aging-us.com AGING 2020, Vol. 12, No. 18
Research Paper
Pre-incubation with human umbilical cord derived mesenchymal stem cells-exosomes prevents cisplatin-induced renal tubular epithelial cell injury
Zongying Li1, Shuyi Cao1 1Department of Nephrology, Cangzhou Central Hospital, Cangzhou, Hebei Province, China
Correspondence to: Zongying Li; email: [email protected]; https://orcid.org/0000-0002-0163-9928 Keywords: apoptosis, cisplatin, exosomes, renal tubular epithelial cell, viability nephrotoxicity Received: February 29, 2020 Accepted: June 4, 2020 Published: September 23, 2020
Copyright: © 2020 Li and Cao. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
ABSTRACT
Purpose: The administration of cisplatin is limited due to its nephrotoxicity, and prevention of this nephrotoxicity of cisplatin is difficult. Mesenchymal stem cell (MSC)-derived exosomes have been implicated as a novel therapeutic approach for tissue injury. Results: In vitro, the NRK cells pre-incubated with HUMSC-exosomes increased the Cp-inhibited cell viability, proliferation activity, and the cell proportion in G1-phase and inhibited Cp-induced cell apoptosis. Furthermore, the expression levels of apoptotic marker proteins Bim, Bad, Bax, cleaved caspase-3, and cleaved caspase-9 induced by Cp in the NRK cells were decreased by pre-incubating with HUMSC-exosomes. Conclusion: Our findings indicated that the exosomes from HUMSCs can effectively increase the survival rate and inhibit cell apoptosis of NRK cells. Therefore, pre-treatment of HUMSC-exosomes may be a new method to improve the therapeutic effect of cisplatin. Patients and methods: Exosomes were isolated from human umbilical cord derived mesenchymal stem cells (HUMSCs). Co-culture of normal rat renal tubular epithelial cells (NRK) and the absorption of exogenous exosomes by NRK cells were examined in vitro. Then the NRK cells were incubated with exosomes from HUMSCs and cisplatin (Cp). Cells were harvested for MTT assay, cloning formation, flow cytometry, and Western blot.
www.aging-us.com 18009 AGING
pathways [7]. As an important substance in the
secretion of paracrine cells, exosomes play a significant
role in promoting cartilage regeneration, reducing
ischemia-reperfusion injury and liver and kidney
damage [8–11]. Exosomes are biologically active
extracellular vesicles secreted by living cells, ranging in
size from 30 to 200 nm, which contain abundant
biologically active substances such as miRNA, mRNA,
and protein [12]. Therefore, exosomes can participate in
the regulation of many life activities, and play a greater
role in information transmission, disease diagnosis and
treatment [13, 14]. Studies have shown that exosomes
can effectively reduce the nephrotoxicity of glycerol,
gentamicin and cyclosporine by inhibiting oxidative
stress [15, 16]. The research implies that exosomes from
MSCs may be a novel stem cell-based therapy for
kidney diseases.
Therefore, exosomes may be able to reduce Cp-induced
kidney damage. In this work, we selected HUMSC-
derived exosomes, which confirmed that it can protect
and prevent Cp-induced kidney damage. Furthermore,
we investigated the protective mechanism of Cp-induced
renal tubular cytotoxicity by exosomes, and provided
experimental evidence for further clinical research.
RESULTS
Characterization and identification of exosomes
derived from HUMSCs
The particle size parameters of the exosomes were
measured by TEM and DLS. The results showed that
the exosomes were microvesicles with a diameter of 80
to 110 nm (Figure 1A), and the peak size of the particle
Figure 1. Identification of exosomes from Human umbilical cord derived mesenchymal stem cells (HUMSCs). (A) Observation of the shape and size of exosomes by transmission electron microscopy. (B) Measurement of the size of exosomes by dynamic light scattering. (C) Zeta potential of the exosomes. (D) The expression of CD9 and CD63, the surface markers of exosomes by Western blot.
www.aging-us.com 18010 AGING
size distribution was 103 nm (Figure 1B). The zeta
potential of the exosomes was -24.15±3.1 mV (Figure
1C). Western blot results showed that the exosomes
surface markers CD9 and CD63 were highly expressed
(Figure 1D). These results suggest that HUMSC-
exosomes were successfully separated.
The exosomes were taken up by NRK cells
NRK cells and the exosomes were co-cultured for 6 h.
The confocal microscopy observation results showed
that Dil-labelled exosomes (red) were taken up by NRK
cells, successfully (Figure 2A, 2B).
Exosomes protect against the injury of NRK cells
induced by Cp
The viability of NRK cells co-cultured with exosomes were
tested after treating with 5 μM, 10 μM, 20 μM, 40 μM, 80
μM, and 160 μM of Cp, respectively. The MTT results
illustrated that NRK cells co-cultured with exosomes for
12 h and 24 h facilitated the viability, while which was
inhibited by 10 μM, 20 μM, 40 μM, 80 μM, and 160 μM
of Cp (Figure 3A). The colony formation of NRK cells
was tested after treating with Cp, Exo1h+Cp, Exo6h+Cp,
Exo12h+Cp, and Exo24h+Cp, respectively. Compared
with the Control group, the number of cell colony in the
Cp group was decreased. However, relative to the Cp
group, the number of cell colony was upregulated in the
Exo6h+Cp, Exo12h+Cp, and Exo24h+Cp groups (Figure
3B, 3C), indicating that HUMSC-exosomes relieved Cp-
induced injury of NRK cells.
Exosomes attenuates Cp induced NRK cells
apoptosis
The apoptosis of NRK cells was tested after treating
with Exo1h+Cp, Exo6h+Cp, Exo12h+Cp, and
Exo24h+Cp. Compared with the Control group, the
apoptosis levels of the Cp group were upregulated
(Figure 4A). However, relative to the Cp group, the
apoptosis levels were downregulated in the Exo1h+Cp,
Exo6h+Cp, Exo12h+Cp, and Exo24h+Cp groups
(Figure 4A).
Figure 2. He exosomes were taken up by NRK. (A) After NRK co-cultured with exosomes, the location of Dil (red), the marker of exosomes, and nucleus (blue) were observed by confocal microscopy. (B) The changes of fluorescence intensity of Dil were analyzed by ImageJ.
www.aging-us.com 18011 AGING
Exosomes regulates the expression of apoptotic
marker proteins in NRK cells treated with Cp
To further clarify the protective mechanism of
HUMSC-exosomes on apoptosis of kidney cells, the
expression levels of apoptotic marker proteins Bax, Bid,
Bim, Bcl-2, cleaved caspase-3, and cleaved caspase-9
were measured by Western blot. Compared with the
Control group, the level of Bcl-2 was decreased and the
levels of Bax, Bid, Bim, cleaved caspase-3, and cleaved
caspase-9 were upregulated in the Cp group (Figure
4B). However, relative to the Cp group, the levels of
Bcl-2 were upregulated and the levels of Bax, Bid, Bim,
cleaved caspase-3, and cleaved caspase-9 were
downregulated in the Cp group in the Exo1h+Cp,
Exo6h+Cp, Exo12h+Cp, and Exo24h+Cp groups
(Figure 4B). It was illustrated that HUMSC-exosomes
inhibited the NRK cells apoptosis induced by Cp.
Exosomes regulates the cell cycle progression of
NRK cells
The changes of cell cycle progression were measured
after treating with Exo1h+Cp, Exo6h+Cp, Exo12h+Cp,
and Exo24h+Cp. Compared with the Control group, the
proportion of the cells in G1-phase in the Cp group was
decreased (Figure 5) and that of the cells in the G2-phase
was increased (Figure 5). However, relative to the Cp
group, the proportion of the cells in G1-phase in the
Exo24h+Cp group was increased (Figure 5), suggesting
that HUMSC-exosomes could improve cycle progression
of NRK cells.
Figure 3. Cell viability and colony formation detection. (A) After NRK co-cultured with exosomes and Cp, the percentage of cell viability was measured by MTT assay; *, p < 0.05, **, p < 0.01, ***, p < 0.001. (B) and (C) The changes of colony number were measured by colony formation assay. *, p < 0.05 vs. Control; #, p < 0.05 vs. Exo1h+Cp; &, p < 0.05 vs. Exo6h+Cp; $, p < 0.05 vs. Exo12h+Cp.
www.aging-us.com 18012 AGING
DISCUSSION
Cp is a potent anticancer agent and its mechanism of
action may be related to its high intracellular reactants.
In an aqueous environment in a cell, Cp forms a
conjugate with intracellular glutathione, protein, RNA,
and DNA, and crosslinks with the purine base of DNA,
interfering with DNA repair mechanisms, leading to
DNA damage, further induction. Thus, it induces cancer
cells to be apoptotic, but they are also toxic to normal
cells [17]. Cp and its hydrated or hydroxyl metabolites
are excreted primarily through the kidneys. Because of
low molecular weight and no charge of Cp, the free Cp
in plasma is easily filtered by the glomerulus, which
results in a concentration of 5 times that in the proximal
tubular epithelial cells. It is consequently more sensitive
to the toxic effects of Cp, and the nephrotoxicity of Cp
is most serious. However, the nephrotoxicity caused by
Cp is currently lacking effective prevention and
treatment methods [18]. In the present study, Cp with
gradually elevated concentration decreased the viability
and colony formation of the NRK with dose-dependent.
It was indicated that Cp was highly toxic to the NRK.
Furthermore, studies have shown that Cp damages
proximal tubular epithelial cells, leading to apoptosis of
renal tubular cells mainly involved in mitochondria-
mediated endogenous pathways, death receptor-
mediated exogenous pathways and endoplasmic
reticulum stress pathways [19]. We also verified the
induction effect of Cp on NRK apoptosis in the present
study, which was consistent with previous research
results.
Figure 4. Effect of different groups on NRK apoptosis. (A) Apoptosis was tested by Annexin V-FITC/PI staining method. (B) The protein levels of Bax, Bid, Bim, Bcl-2, cleaved caspase-3, and cleaved caspase-9 were measured by Western blot, and analyzed by ImageJ. * P< 0.05 vs. Control; &, p < 0.05 vs. Exo1h+Cp.
www.aging-us.com 18013 AGING
Figure 5. Effect of different groups on NRK cell cycle progression. The cell cycle progression was tested by flow cytometry.
www.aging-us.com 18014 AGING
In recent years, as the main biological component of
paracrine secretion of stem cells, exosomes reduce the
possibility of stem cells forming tumors in vivo because
they do not have the ability to divide and differentiate
[20, 21]. Compared with mesenchymal stem cell
transplantation therapy, exosomes have relative
stability. Exosomes are distinguished by their size from
other vesicles secreted by mesenchymal stem cells,
ranging from 30-200 nm in diameter to densities
ranging from 1.10 to 1.20 g/mL [12]. The key step in
the present study is the extraction of exosomes. The
present study used the low temperature ultra-high speed
centrifugation method to obtain relatively pure
exosomes. Under electron microscope, the exosomes
were mostly concentrated at 80-110 nm, and can
express CD9 and CD63 marker surface proteins.
Consistent with the biological characteristics and
identification criteria of exosomes, it indicated that the
exosomes of HUMSCs were successfully isolated.
Furthermore, in pig and mouse models of myocardial
ischemia-reperfusion injury in mice, Timmers et al. [22]
found that the medium reduced myocardial infarct size
by 60% and 50%, respectively, when intravenously
injected into conditioned medium of mesenchymal stem
cells. It was further confirmed that the size of the active
medium acting was in the range of 50-200 nm. The
study found that mesenchymal stem cell conditioned
medium can reduce myocardial infarct size in mice, but
conditioned medium without exosomes does not have
this function [23]. All of the above studies have
demonstrated that mesenchymal stem cells mainly
function through exosomes in their supernatants. In the
present study, notably, when exosomes were co-
cultured with Cp-treated NRK, the cell viability of NRK
was remarkably higher than that of the Cp-treatment
alone. In addition, by increasing the culture time of
exosomes and NRK, it was found that the proliferative
capacity of NRK was positively correlated with the
culture time of exosomes. These results suggested that
exosomes from HUMSCs promoted renal endothelial
cell proliferation.
In order to explore the protection of the exosomes on
Cp-induced NRK cell injury, its effect on apoptosis
was observed. The results showed that the apoptosis
rate of NRK cells was up-regulated after Cp treatment,
and the expression of apoptosis markers Bax, Bid, Bim,
Caspas-3 and -9 were up-regulated. Notably, after the
exosomes were added to the Cp-induced NR, the
apoptotic rate increased significantly, and the
expressions of Bax, Bid, Bim, and Caspas-3 and -9
were all down-regulated, and the expression of Bcl-2
was upregulated. It was indicated that exosomes
promoted the proliferation of NRK cells and inhibit
the apoptosis of cells, which consistent with previous
results in exosomes regulating apoptosis and
proliferation of endothelial cells [24]. Our further
results showed that the cells incubated with exosomes
alleviated cell cycle inhibition caused by Cp. In recent
years, a large number of studies have shown that
exosome miRNAs play an important role in the
occurrence and development of diseases. Exosomes can
selectively encapsulate miRNAs and stably transfer
miRNAs to recipient cells and function [25].
Additionally, in diseases such as lung cancer, lung
inflammation, and pulmonary fibrosis, exosome
miRNAs regulate the expression of many proliferation-
related and/or apoptosis-related genes [25–27]. For
example, cardiac stem cell-derived exosomes miR-21
inhibited cardiomyocyte apoptosis by targeting binding
to programmed cell death factor 4 [28]. We
hypothesized that the protective effect of exosomes on
NRK cells may be related to the regulation of cell
proliferation and apoptosis-related genes by the
miRNAs they carry. However, this speculation still
needs further experimental verification.
The clinical application of exosomes depends on the
technical breakthrough of exosome-based drug delivery
system. At present, exosomes have been found to play
an important role in various health and disease models
through the transmission of molecular information.
Exosomes are recognized as biomarkers and prognostic
factors of diseases and have important clinical
diagnostic and therapeutic significance. In addition,
they have the potential to be used clinically as a vehicle
for gene and drug delivery. Exosomes themselves are
quite inert, but when they fuse with the cell membrane,
they can deliver the materials and signals they carry to
the recipient cell and change its biological function.
Therefore, exosomes are potential carriers for
nanometer drug delivery or gene therapy. As natural
carriers of functional small RNAs and proteins,
exosomes can be used to deliver various ribonucleic
acid molecules, peptides and synthetic drugs in the field
of drug delivery.
In this study, the functionally exosomal miRNAs have
not been screened and explored. In the later stage, we
will screen for miRNAs in the process of regulating the
function of renal tubular epithelial cells by miRNA
microarray or high throughput sequencing technology.
In summary, exosomes from HUMSCs can significantly
reduce Cp-induced NRK cell injury, which may be
related to the up-regulation of Bcl-2 in renal tubular
cells and inhibition of Bax, Bid, and Bim expressions,
thereby inhibiting downstream caspase-3 and caspase-9
activation. Exosomes may be an ideal Cp nephrotoxicity
control drug and deserve further study. And these
findings provide a basis for the future use of exosomes
as a new biological therapeutic approach for renal
diseases and injuries.
www.aging-us.com 18015 AGING
CONCLUSION
In this study, the functionally exosomal miRNAs have
not been screened and explored. In the later stage, we
will screen for miRNAs in the process of regulating the
function of renal tubular epithelial cells by miRNA
microarray or high throughput sequencing technology.
In summary, exosomes from HUMSCs can significantly
reduce Cp-induced NRK cell injury, which may be
related to the up-regulation of Bcl-2 in renal tubular
cells and inhibition of Bax, Bid, and Bim expressions,
thereby inhibiting downstream caspase-3 and caspase-9
activation. Exosomes may be an ideal Cp nephrotoxicity
control drug and deserve further study. And these
findings provide a basis for the future use of exosomes
as a new biological therapeutic approach for renal
diseases and injuries.
MATERIALS AND METHODS
Cell culture
HUMSCs were purchased from Cyagen Biosciences
(Guangzhou, China). HUMSCs were culture in DMEM
containing 10% fetal bovine serum at 37 °C and in 5%
CO2 incubator. Furthermore, normal rat renal tubular
epithelial cells (NRK) were purchased from Procell
(Wuhan, China) and were cultured in DMEM
(PM150210) containing 10% fetal bovine serum at 37
°C and in 5% CO2 incubator.
Exosomes separation
The culture supernatant of HUMSCs in 4-6 generations
was collected and the exosomes were extracted
according to the instructions of the Invitrogen 4478359
Total Exosome Isolation Reagent (Gibco, Invitrogen,
UK). Briefly, the culture supernatant was transferred to
a high-speed centrifuge tube, centrifuge at 4°C, 2000 g
for 30 min, the supernatant was taken and transferred to
a new high-speed centrifuge tube, and the cell
supernatant was added (cell supernatant: reagent = 2:1).
After fully mixing with vortex, the mixture was placed
in a refrigerator and incubated at 4 °C overnight. After
centrifugation at 4 °C, 10000 g for 60 min, the
precipitate was resuspended in 100 μl of cold PBS as a
suspension of exosomes and stored at -80 °C.
Identification of exosomes
Transmission electron microscope (TEM) was used to
observe the morphology of exosomes. 10 μl of the
exosomes were separated and purified, and diluted with
an equal volume of balanced salt PBS solution. The
sample was added dropwise to a sample-loaded copper
mesh, and was allowed to stand at room temperature for
1 minute. Then the excess liquid was gently removed
using filter paper. After that, the sample was negatively
stained with 3% sodium phosphotungstate solution (pH
6.8) for 5 minutes at RT. After gently washing with
double distilled water, the sample was air-dried at room
temperature, and observed under a transmission electron
microscope. In addition, dynamic light scattering (DLS)
was used to detect the size of exosomes. Briefly, 10 μl
of the exosomes were separated and purified, and
diluted with PBS solution to measure the size using a
Malvern laser particle size analyzer.
Western blot
Western Blot was used to identify the expressions of
CD9 and CD63 on the surface of exosomes and the
expressions of Bax, Bid, Bim, Bcl-2, cleaved caspase-3,
and cleaved caspase-9 in NRK cells. Total proteins
were obtained using lysis buffer, and then quantitated
by bicinchoninic acid kit (Beyotime, Shanghai, China).
Following sample separating and transferring into
PVDF membranes, membranes were immerged in 5%
nonfat milk. Next, primary antibodies of CD9, CD6,
Bax, Bid, Bim, Bcl-2, cleaved caspase-3, cleaved
caspase-9 (1: 800, Abcam), and β-actin (1: 1000,
Beyotime), respectively, were used for immunoblotting
of the membranes overnight at 4°C. After the incubation
with second antibody (1:5000, Jackson, USA), the
protein levels were detected by enhanced
chemiluminescence (ECL, Millipore, USA).
Observation of cell uptake by laser confocal
microscopy
Dil (Thermo Fisher Scientific, Invitrogen, catalog
number: D282) was used to mark the exosomes. After
staining for 30 min, the exosomes were washed with
PBS and collected by centrifugation at 10000 g for 60
min to obtain the Dil-labeled exosomes. NRK cells
were planted in confocal dishes. After the cells were
attached overnight, 20 μg/ml of Dil-labeled exosomes
were added to the dish, and after 1, 4, 8, 12, and 24 h of
culture, the cells were washed with PBS and fixed with
4% paraformaldehyde for 30 min. Subsequently, after
washing with PBS, the cells were permeabilized for 15
min using 0.2% Triton-100. Nucleus were stained with
Hoechst 33342, and photographed using laser confocal
after washing with PBS.
Cell viability by MTT (thiazolyl blue tetrazolium
bromide)
NRK cells were pre-incubated with exosomes from HUMSCs for 1 h, 6 h, 12 h, and 24h, followed by
treatment with Cp at 5, 10, 20, 40, 80, and 160 μM in 96-well plates. After co-culturing 24h, cell viability was
www.aging-us.com 18016 AGING
measured using the MTT assay. MTT solution (5 g/L) was added at 10 μL/well. After incubating for 4 h, the
supernatant was removed, 150 μL of DMSO was added to each well, and the cells were gently shaken for 30 s.
100 μL of each well was aspirated into the enzyme label, and then the absorbance value (OD) at 570 nm
was measured by a microplate reader. The percentage of
cell activity was used as an evaluation index for the effect of nanoparticles on cell viability. The calculation
formula was: percentage of cell activity (%) = (OD value of each well in the infected group - blank OD
value) / (Control group OD mean - blank OD value) ×
100%, control group cell activity percentage was 100%.
Colony formation assay
NRK cells in the Control, Cp, Exo1h+Cp, Exo6h+Cp, Exo12h+Cp, and Exo24h+Cp. groups were respectively
mixed with 0.3% Noble agar in 10% FBS supplemented
DMEM, which were seeded as the upper agar layer of the agar plates. The cells were then incubated in a 37 ˚C
incubator for 7 days, and the number of colonies was counted.
Cell apoptosis by flow cytometry
NRK cells were seeded in 6-well plates overnight, 200 μg/ml of exosomes was added. After co-culturing for 1
h, 6 h, 12 h, and 24 h, 20 μM Cp was added in to the plates. The NRK cells were divided into six groups: no
treatment group (Control), Cp group, co-culture with
exosomes combined with Cp treatment groups for 1 h (Exo1h+Cp), 6 h (Exo6h+Cp), 12 h (Exo12h+Cp), and
24 h (Exo24h+Cp). After Cp treatment for 24 hours, cell apoptosis was detected by flow cytometry using
Annexin-PI staining.
Cell cycle detection by flow cytometry
The NRK cells were seeded in 6-well plates overnight
were pre-incubated with exosomes from HUMSCs for 1 h, 6 h, 12 h, and 24h, followed by treatment with 20 μM
Cp which prepared by a medium containing 200 μg/ml
of exosomes. Then, the cells in each group were collected. 5X104 cells in each group were washed twice
with PBS, and fixed in 1 mL of 70% ice ethanol for 24 h at 4 °C. Then, the cells were washed twice with PBS
and were added with propidium iodide staining solution
at 4 °C for 30 min. Cell cycle distribution was measured using a flow cytometer.
Statistical analysis
GraphPad Prism 6.05 was used for statistical analysis of
experimental data. One-way ANOVA and Student's t
test were used for comparative analysis of differences. P < 0.05 was considered statistically significant.
AUTHOR CONTRIBUTIONS
Zongying Li performed the majority of experiments and
analyzed the data; Shuyi Cao performed the molecular
investigations; Zongying Li designed and coordinated
the research; Shuyi Cao rote the paper.
CONFLICTS OF INTEREST
The author reports no conflicts of interest in this work.
FUNDING
This research did not receive any specific grant from
funding agencies in the public, commercial, or not-for-
profit sectors.
REFERENCES
1. Lopes JA, Fernandes P, Jorge S, Resina C, Santos C, Pereira A, Neves J, Antunes F, Gomes da Costa A. Long-term risk of mortality after acute kidney injury in patients with sepsis: a contemporary analysis. BMC Nephrol. 2010; 11:9.
https://doi.org/10.1186/1471-2369-11-9 PMID:20525222
2. Kodama A, Watanabe H, Tanaka R, Kondo M, Chuang VT, Wu Q, Endo M, Ishima Y, Fukagawa M, Otagiri M, Maruyama T. Albumin fusion renders thioredoxin an effective anti-oxidative and anti-inflammatory agent for preventing cisplatin-induced nephrotoxicity. Biochim Biophys Acta. 2014; 1840:1152–62.
https://doi.org/10.1016/j.bbagen.2013.12.007 PMID:24361613
3. Amirshahrokhi K, Khalili AR. Thalidomide ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in an experimental model. Inflammation. 2015; 38:476–84.
https://doi.org/10.1007/s10753-014-9953-7 PMID:24950782
4. Yoshida T, Kumagai H, Kohsaka T, Ikegaya N. Protective effects of relaxin against cisplatin-induced nephrotoxicity in rats. Nephron Exp Nephrol. 2014; 128:9–20.
https://doi.org/10.1159/000365852 PMID:25403022
5. Valentovic MA, Ball JG, Brown JM, Terneus MV, McQuade E, Van Meter S, Hedrick HM, Roy AA, Williams T. Resveratrol attenuates cisplatin renal cortical cytotoxicity by modifying oxidative stress. Toxicol In Vitro. 2014; 28:248–57.
https://doi.org/10.1016/j.tiv.2013.11.001 PMID:24239945
www.aging-us.com 18017 AGING
6. Russell KA, Chow NH, Dukoff D, Gibson TW, LaMarre J, Betts DH, Koch TG. Characterization and immunomodulatory effects of canine adipose tissue-and bone marrow-derived mesenchymal stromal cells. PLoS One. 2016; 11:e0167442.
https://doi.org/10.1371/journal.pone.0167442 PMID:27907211
7. Huang S, Wu Y, Gao D, Fu X. Paracrine action of mesenchymal stromal cells delivered by microspheres contributes to cutaneous wound healing and prevents scar formation in mice. Cytotherapy. 2015; 17:922–31.
https://doi.org/10.1016/j.jcyt.2015.03.690 PMID:25939802
8. Zhang S, Chu WC, Lai RC, Lim SK, Hui JH, Toh WS. Exosomes derived from human embryonic mesenchymal stem cells promote osteochondral regeneration. Osteoarthritis Cartilage. 2016; 24:2135–40.
https://doi.org/10.1016/j.joca.2016.06.022 PMID:27390028
9. Nagaishi K, Mizue Y, Chikenji T, Otani M, Nakano M, Konari N, Fujimiya M. Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes. Sci Rep. 2016; 6:34842.
https://doi.org/10.1038/srep34842 PMID:27721418
10. Shabbir A, Cox A, Rodriguez-Menocal L, Salgado M, Van Badiavas E. Mesenchymal Stem Cell Exosomes Induce Proliferation and Migration of Normal and Chronic Wound Fibroblasts, and Enhance Angiogenesis In Vitro. Stem Cells Dev. 2015; 24:1635–47.
https://doi.org/10.1089/scd.2014.0316 PMID:25867197
11. Li T, Yan Y, Wang B, Qian H, Zhang X, Shen L, Wang M, Zhou Y, Zhu W, Li W, Xu W. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev. 2013; 22:845–54.
https://doi.org/10.1089/scd.2012.0395 PMID:23002959
12. Vrijsen KR, Maring JA, Chamuleau SA, Verhage V, Mol EA, Deddens JC, Metz CH, Lodder K, van Eeuwijk EC, van Dommelen SM, Doevendans PA, Smits AM, Goumans MJ, Sluijter JP. Exosomes from cardiomyocyte progenitor cells and mesenchymal stem cells stimulate angiogenesis via EMMPRIN. Adv Healthc Mater. 2016; 5:2555–65.
https://doi.org/10.1002/adhm.201600308 PMID:27570124
13. Zhang J, Li S, Li L, Li M, Guo C, Yao J, Mi S. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics. 2015; 13:17–24.
https://doi.org/10.1016/j.gpb.2015.02.001 PMID:25724326
14. Li W, Li C, Zhou T, Liu X, Liu X, Li X, Chen D. Role of exosomal proteins in cancer diagnosis. Mol Cancer. 2017; 16:145.
https://doi.org/10.1186/s12943-017-0706-8 PMID:28851367
15. Zhou Y, Xu H, Xu W, Wang B, Wu H, Tao Y, Zhang B, Wang M, Mao F, Yan Y, Gao S, Gu H, Zhu W, Qian H. Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro. Stem Cell Res Ther. 2013; 4:34.
https://doi.org/10.1186/scrt194 PMID:23618405
16. Lou G, Chen Z, Zheng M, Liu Y. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Exp Mol Med. 2017; 49:e346.
https://doi.org/10.1038/emm.2017.63 PMID:28620221
17. Kitada M, Koya D. Renal protective effects of resveratrol. Oxid Med Cell Longev. 2013; 2013:568093.
https://doi.org/10.1155/2013/568093 PMID:24379901
18. Manohar S, Leung N. Cisplatin nephrotoxicity: a review of the literature. J Nephrol. 2018; 31:15–25.
https://doi.org/10.1007/s40620-017-0392-z PMID:28382507
19. Abd El-Haleim EA, Bahgat AK, Saleh S. Resveratrol and fenofibrate ameliorate fructose-induced nonalcoholic steatohepatitis by modulation of genes expression. World J Gastroenterol. 2016; 22:2931–48.
https://doi.org/10.3748/wjg.v22.i10.2931 PMID:26973390
20. Patel DB, Gray KM, Santharam Y, Lamichhane TN, Stroka KM, Jay SM. Impact of cell culture parameters on production and vascularization bioactivity of mesenchymal stem cell-derived extracellular vesicles. Bioeng Transl Med. 2017; 2:170–79.
https://doi.org/10.1002/btm2.10065 PMID:28932818
21. Cai ZY, Xiao M, Quazi SH, Ke ZY. Exosomes: a novel therapeutic target for Alzheimer’s disease? Neural Regen Res. 2018; 13:930–35.
https://doi.org/10.4103/1673-5374.232490 PMID:29863025
22. Timmers L, Lim SK, Arslan F, Armstrong JS, Hoefer IE, Doevendans PA, Piek JJ, El Oakley RM, Choo A, Lee CN, Pasterkamp G, de Kleijn DP. Reduction of myocardial infarct size by human mesenchymal stem cell conditioned medium. Stem Cell Res. 2007; 1:129–37.
https://doi.org/10.1016/j.scr.2008.02.002
www.aging-us.com 18018 AGING
PMID:19383393
23. Martinez MC, Andriantsitohaina R. Microparticles in angiogenesis: therapeutic potential. Circ Res. 2011; 109:110–19.
https://doi.org/10.1161/CIRCRESAHA.110.233049 PMID:21700952
24. Chen L, Yang W, Guo Y, Chen W, Zheng P, Zeng J, Tong W. Exosomal lncRNA GAS5 regulates the apoptosis of macrophages and vascular endothelial cells in atherosclerosis. PLoS One. 2017; 12:e0185406.
https://doi.org/10.1371/journal.pone.0185406 PMID:28945793
25. Yuan T, Huang X, Woodcock M, Du M, Dittmar R, Wang Y, Tsai S, Kohli M, Boardman L, Patel T, Wang L. Plasma extracellular RNA profiles in healthy and cancer patients. Sci Rep. 2016; 6:19413.
https://doi.org/10.1038/srep19413 PMID:26786760
26. Li B, Ding CM, Li YX, Peng JC, Geng N, Qin WW. MicroRNA-145 inhibits migration and induces apoptosis in human non-small cell lung cancer cells through regulation of the EGFR/PI3K/AKT signaling pathway. Oncol Rep. 2018; 40:2944–54.
https://doi.org/10.3892/or.2018.6666 PMID:30226581
27. Ju M, Liu B, He H, Gu Z, Liu Y, Su Y, Zhu D, Cang J, Luo Z. MicroRNA-27a alleviates LPS-induced acute lung injury in mice via inhibiting inflammation and apoptosis through modulating TLR4/MyD88/NF-κB pathway. Cell Cycle. 2018; 17:2001–18.
https://doi.org/10.1080/15384101.2018.1509635 PMID:30231673
28. Xiao J, Pan Y, Li XH, Yang XY, Feng YL, Tan HH, Jiang L, Feng J, Yu XY. Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4. Cell Death Dis. 2016; 7:e2277.
https://doi.org/10.1038/cddis.2016.181 PMID:27336721